Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Adagio Medical Holdings ( (ADGM) ) has issued an announcement.
On December 15, 2025, Adagio Medical Holdings, Inc. held its 2025 Annual Meeting of Stockholders. During the meeting, stockholders voted on two proposals: the election of two directors and the ratification of an independent accounting firm. Both nominees, Todd Usen and James L. Cox, M.D., were elected as directors, and WithumSmith+Brown, PC was ratified as the independent accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (ADGM) stock is a Hold with a $0.90 price target. To see the full list of analyst forecasts on Adagio Medical Holdings stock, see the ADGM Stock Forecast page.
Spark’s Take on ADGM Stock
According to Spark, TipRanks’ AI Analyst, ADGM is a Neutral.
Adagio Medical Holdings’ overall stock score is primarily impacted by its weak financial performance and valuation, which are significant concerns. However, recent corporate events, including successful fundraising and promising study results, provide some positive outlook for future growth potential.
To see Spark’s full report on ADGM stock, click here.
More about Adagio Medical Holdings
Average Trading Volume: 374,846
Technical Sentiment Signal: Sell
Current Market Cap: $20.78M
See more data about ADGM stock on TipRanks’ Stock Analysis page.